Schonfeld Strategic Advisors’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q4 | – | Sell |
-501,279
| Closed | -$12.6M | – | 2464 |
|
|
2025
Q3 | $12.8M | Buy |
501,279
+369,415
| +280% | +$9.12M | 0.07% | 282 |
|
|
2025
Q2 | $3.2M | Sell |
131,864
-249,370
| -65% | -$5.82M | 0.02% | 754 |
|
|
2025
Q1 | $9.66M | Buy |
381,234
+310,737
| +441% | +$8.13M | 0.06% | 334 |
|
|
2024
Q4 | $1.87M | Sell |
70,497
-40,731
| -37% | -$1.1M | 0.01% | 863 |
|
|
2024
Q3 | $3.22M | Sell |
111,228
-125,588
| -53% | -$3.66M | 0.02% | 698 |
|
|
2024
Q2 | $6.63M | Sell |
236,816
-1,188,783
| -83% | -$32.7M | 0.04% | 477 |
|
|
2024
Q1 | $39.6M | Buy |
1,425,599
+1,055,367
| +285% | +$29.3M | 0.26% | 49 |
|
|
2023
Q4 | $10.7M | Buy |
370,232
+83,954
| +29% | +$2.54M | 0.07% | 334 |
|
|
2023
Q3 | $9.5M | Buy |
286,278
+282,878
| +8,320% | +$10M | 0.07% | 365 |
|
|
2023
Q2 | $125K | Sell |
3,400
-219,062
| -98% | -$8.53M | ﹤0.01% | 1685 |
|
|
2023
Q1 | $9.08M | Sell |
222,462
-60,030
| -21% | -$2.59M | 0.09% | 309 |
|
|
2022
Q4 | $14.5M | Sell |
282,492
-48,326
| -15% | -$2.32M | 0.12% | 234 |
|
|
2022
Q3 | $14.5M | Buy |
330,818
+295,798
| +845% | +$14.4M | 0.12% | 234 |
|
|
2022
Q2 | $1.84M | Sell |
35,020
-345,334
| -91% | -$17.6M | 0.02% | 771 |
|
|
2022
Q1 | $19.7M | Buy |
380,354
+344,030
| +947% | +$17.9M | 0.18% | 123 |
|
|
2021
Q4 | $2.15M | Sell |
36,324
-474,972
| -93% | -$23.5M | 0.02% | 681 |
|
|
2021
Q3 | $22M | Buy |
+511,296
| New | +$22.7M | 0.23% | 101 |
|
|
2021
Q2 | – | Sell |
-209,961
| Closed | -$7.61M | – | 2213 |
|
|
2021
Q1 | $7.61M | Buy |
209,961
+170,461
| +432% | +$6.05M | 0.09% | 297 |
|
|
2020
Q4 | $1.45M | Buy |
+39,500
| New | +$1.45M | 0.02% | 690 |
|
|
2020
Q3 | – | Sell |
-31,897
| Closed | -$989K | – | 1580 |
|
|
2020
Q2 | $989K | Sell |
31,897
-67,883
| -68% | -$2.31M | 0.03% | 605 |
|
|
2020
Q1 | $3.09M | Buy |
99,780
+82,705
| +484% | +$2.82M | 0.19% | 118 |
|
|
2019
Q4 | $635K | Buy |
+17,075
| New | +$608K | 0.02% | 654 |
|
|
2019
Q3 | – | Sell |
-133,924
| Closed | -$5.5M | – | 1181 |
|
|
2019
Q2 | $5.5M | Sell |
133,924
-163,819
| -55% | -$6.51M | 0.19% | 129 |
|
|
2019
Q1 | $12M | Sell |
297,743
-44,319
| -13% | -$1.77M | 0.42% | 53 |
|
|
2018
Q4 | $14.2M | Buy |
+342,062
| New | +$14.2M | 0.54% | 26 |
|
|
2017
Q3 | – | Sell |
-7,575
| Closed | -$241K | – | 740 |
|
|
2017
Q2 | $241K | Buy |
+7,575
| New | +$239K | 0.02% | 524 |
|
|
2017
Q1 | – | Sell |
-10,262
| Closed | -$316K | – | 700 |
|
|
2016
Q4 | $316K | Buy |
+10,262
| New | +$313K | 0.04% | 414 |
|
|
2016
Q3 | – | Sell |
-12,171
| Closed | -$406K | – | 510 |
|
|
2016
Q2 | $406K | Sell |
12,171
-21,557
| -64% | -$688K | 0.09% | 263 |
|
|
2016
Q1 | $948K | Buy |
+33,728
| New | +$963K | 0.39% | 75 |
|
Other funds holding PFE
VCM
VPM
Schonfeld Strategic Advisors's PFE Position: Q4 2025 in Review
Schonfeld Strategic Advisors sold out of Pfizer (PFE) in Q4 2025, closing a stake of 501,279 shares — an estimated $12.6M sold.
Schonfeld Strategic Advisors first reported a position in PFE in Q1 2016 and held it in 29 quarters. The position peaked at $39.6M in Q1 2024. 2,905 funds tracked by Wall St. Rank hold PFE as of Q4 2025.
- Schonfeld Strategic Advisors reported no remaining Pfizer position as of Q4 2025 after selling out during the quarter.
- Schonfeld Strategic Advisors sold 501,279 Pfizer shares in Q4 2025, an estimated $12.6M.
- Schonfeld Strategic Advisors first reported a position in Pfizer in Q1 2016 and held it in 29 quarters.
- Schonfeld Strategic Advisors's Pfizer position peaked at $39.6M in Q1 2024.
- 2,905 funds tracked by Wall St. Rank held Pfizer as of Q4 2025.
Based on Schonfeld Strategic Advisors's 13F filing for Q4 2025, filed 17 Feb 2026.